Literature DB >> 22492561

Essential role of interleukin-6 in post-stroke angiogenesis.

Karen Gertz1, Golo Kronenberg, Roland E Kälin, Tina Baldinger, Christian Werner, Mustafa Balkaya, Gina D Eom, Julian Hellmann-Regen, Jan Kröber, Kelly R Miller, Ute Lindauer, Ulrich Laufs, Ulrich Dirnagl, Frank L Heppner, Matthias Endres.   

Abstract

Ambivalent effects of interleukin-6 on the pathogenesis of ischaemic stroke have been reported. However, to date, the long-term actions of interleukin-6 after stroke have not been investigated. Here, we subjected interleukin-6 knockout (IL-6(-/-)) and wild-type control mice to mild brain ischaemia by 30-min filamentous middle cerebral artery occlusion/reperfusion. While ischaemic tissue damage was comparable at early time points, IL-6(-/-) mice showed significantly increased chronic lesion volumes as well as worse long-term functional outcome. In particular, IL-6(-/-) mice displayed an impaired angiogenic response to brain ischaemia with reduced numbers of newly generated endothelial cells and decreased density of perfused microvessels along with lower absolute regional cerebral blood flow and reduced vessel responsivity in ischaemic striatum at 4 weeks. Similarly, the early genomic activation of angiogenesis-related gene networks was strongly reduced and the ischaemia-induced signal transducer and activator of transcription 3 activation observed in wild-type mice was almost absent in IL-6(-/-) mice. In addition, systemic neoangiogenesis was impaired in IL-6(-/-) mice. Transplantation of interleukin-6 competent bone marrow into IL-6(-/-) mice (IL-6(chi)) did not rescue interleukin-6 messenger RNA expression or the early transcriptional activation of angiogenesis after stroke. Accordingly, chronic stroke outcome in IL-6(chi) mice recapitulated the major effects of interleukin-6 deficiency on post-stroke regeneration with significantly enhanced lesion volumes and reduced vessel densities. Additional in vitro experiments yielded complementary evidence, which showed that after stroke resident brain cells serve as the major source of interleukin-6 in a self-amplifying network. Treatment of primary cortical neurons, mixed glial cultures or immortalized brain endothelia with interleukin 6-induced robust interleukin-6 messenger RNA transcription in each case, whereas oxygen-glucose deprivation did not. However, oxygen-glucose deprivation of organotypic brain slices resulted in strong upregulation of interleukin-6 messenger RNA along with increased transcription of key angiogenesis-associated genes. In conclusion, interleukin-6 produced locally by resident brain cells promotes post-stroke angiogenesis and thereby affords long-term histological and functional protection.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22492561      PMCID: PMC3359750          DOI: 10.1093/brain/aws075

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  72 in total

1.  Serine-threonine protein kinase Akt does not mediate ischemic tolerance after global ischemia in the gerbil.

Authors:  S Namura; I Nagata; H Kikuchi; M Andreucci; A Alessandrini
Journal:  J Cereb Blood Flow Metab       Date:  2000-09       Impact factor: 6.200

2.  Melatonin is protective in necrotic but not in caspase-dependent, free radical-independent apoptotic neuronal cell death in primary neuronal cultures.

Authors:  C Harms; M Lautenschlager; A Bergk; D Freyer; M Weih; U Dirnagl; J R Weber; H Hörtnagl
Journal:  FASEB J       Date:  2000-09       Impact factor: 5.191

3.  Acute neuroprotection by pioglitazone after mild brain ischemia without effect on long-term outcome.

Authors:  Shengbo Ji; Golo Kronenberg; Mustafa Balkaya; Katrin Färber; Karen Gertz; Helmut Kettenmann; Matthias Endres
Journal:  Exp Neurol       Date:  2008-12-25       Impact factor: 5.330

4.  Interleukin-6 acts in the fashion of a classical chemokine on monocytic cells by inducing integrin activation, cell adhesion, actin polymerization, chemotaxis, and transmigration.

Authors:  Thomas Clahsen; Fred Schaper
Journal:  J Leukoc Biol       Date:  2008-09-02       Impact factor: 4.962

5.  STAT3 is a critical regulator of astrogliosis and scar formation after spinal cord injury.

Authors:  Julia E Herrmann; Tetsuya Imura; Bingbing Song; Jingwei Qi; Yan Ao; Thu K Nguyen; Rose A Korsak; Kiyoshi Takeda; Shizuo Akira; Michael V Sofroniew
Journal:  J Neurosci       Date:  2008-07-09       Impact factor: 6.167

Review 6.  Ambivalent aspects of interleukin-6 in cerebral ischemia: inflammatory versus neurotrophic aspects.

Authors:  Shigeaki Suzuki; Kortaro Tanaka; Norihiro Suzuki
Journal:  J Cereb Blood Flow Metab       Date:  2008-11-19       Impact factor: 6.200

Review 7.  Mechanisms and targets for angiogenic therapy after stroke.

Authors:  Deepti Navaratna; Shuzhen Guo; Ken Arai; Eng H Lo
Journal:  Cell Adh Migr       Date:  2009-04-13       Impact factor: 3.405

8.  Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra.

Authors:  Vikas Kaushal; Lyanne C Schlichter
Journal:  J Neurosci       Date:  2008-02-27       Impact factor: 6.167

9.  Social isolation alters neuroinflammatory response to stroke.

Authors:  Kate Karelina; Greg J Norman; Ning Zhang; John S Morris; Haiyan Peng; A Courtney DeVries
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-23       Impact factor: 11.205

10.  Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway.

Authors:  Teresa F Pais; Catarina Figueiredo; Rui Peixoto; Maria H Braz; Sukalyan Chatterjee
Journal:  J Neuroinflammation       Date:  2008-10-09       Impact factor: 8.322

View more
  69 in total

Review 1.  Inflammatory responses in brain ischemia.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Curr Med Chem       Date:  2015       Impact factor: 4.530

2.  Selective knockout of astrocytic Na+ /H+ exchanger isoform 1 reduces astrogliosis, BBB damage, infarction, and improves neurological function after ischemic stroke.

Authors:  Gulnaz Begum; Shanshan Song; Shaoxia Wang; Hanshu Zhao; Mohammad Iqbal H Bhuiyan; Eric Li; Rachel Nepomuceno; Qing Ye; Ming Sun; Michael Joseph Calderon; Donna B Stolz; Claudette St Croix; Simon C Watkins; Yinhuai Chen; Pingnian He; Gary E Shull; Dandan Sun
Journal:  Glia       Date:  2017-09-19       Impact factor: 7.452

3.  Regulatory T-cells within bone marrow-derived stem cells actively confer immunomodulatory and neuroprotective effects against stroke.

Authors:  Elliot G Neal; Sandra A Acosta; Yuji Kaneko; Xunming Ji; Cesario V Borlongan
Journal:  J Cereb Blood Flow Metab       Date:  2018-03-23       Impact factor: 6.200

4.  Magnetic resonance imaging of local and remote vascular remodelling after experimental stroke.

Authors:  Pavel Yanev; Peter R Seevinck; Umesh S Rudrapatna; Mark Jrj Bouts; Annette van der Toorn; Karen Gertz; Golo Kronenberg; Matthias Endres; Geralda A van Tilborg; Rick M Dijkhuizen
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

5.  Blood vitronectin is a major activator of LIF and IL-6 in the brain through integrin-FAK and uPAR signaling.

Authors:  Matthew P Keasey; Cuihong Jia; Lylyan F Pimentel; Richard R Sante; Chiharu Lovins; Theo Hagg
Journal:  J Cell Sci       Date:  2018-02-02       Impact factor: 5.285

Review 6.  The evolving role of neuro-immune interaction in brain repair after cerebral ischemic stroke.

Authors:  Xin Wang; Wei Xuan; Zi-Yu Zhu; Yan Li; Hao Zhu; Ling Zhu; Dan-Yun Fu; Li-Qun Yang; Pei-Ying Li; Wei-Feng Yu
Journal:  CNS Neurosci Ther       Date:  2018-10-22       Impact factor: 5.243

7.  Uric Acid Neuroprotection Associated to IL-6/STAT3 Signaling Pathway Activation in Rat Ischemic Stroke.

Authors:  Alicia Aliena-Valero; Sergio Rius-Pérez; Júlia Baixauli-Martín; Germán Torregrosa; Ángel Chamorro; Salvador Pérez; Juan B Salom
Journal:  Mol Neurobiol       Date:  2020-09-22       Impact factor: 5.590

8.  The dual PPARα/γ agonist aleglitazar increases the number and function of endothelial progenitor cells: implications for vascular function and atherogenesis.

Authors:  C M Werner; S H Schirmer; C Gensch; V Pavlickova; J Pöss; M B Wright; M Böhm; U Laufs
Journal:  Br J Pharmacol       Date:  2014-05       Impact factor: 8.739

9.  Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARγ and 5-HT1A receptors.

Authors:  William H Hind; Timothy J England; Saoirse E O'Sullivan
Journal:  Br J Pharmacol       Date:  2016-02-03       Impact factor: 8.739

10.  Delayed Treatment with Green Tea Polyphenol EGCG Promotes Neurogenesis After Ischemic Stroke in Adult Mice.

Authors:  Jian-Cheng Zhang; Hang Xu; Yin Yuan; Jia-Yi Chen; Yu-Jing Zhang; Yun Lin; Shi-Ying Yuan
Journal:  Mol Neurobiol       Date:  2016-05-20       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.